DISEASE SCANNER
Global Incurable Diseases Tracker
BRCA1/BRCA2 Hereditary Breast-Ovarian Cancer Syndrome
Hereditary cancer syndrome caused by mutations in BRCA1 or BRCA2 tumor suppressor genes. Significantly increased lifetime risk of breast cancer (up to 70%), ovarian cancer (up to 44%), prostate cancer, and pancreatic cancer.
1.2M
15
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Genetic testing
- 2Clinical evaluation
- 3Family history assessment
- 4Specialized laboratory tests
- 5Imaging studies
- 6Biopsy (if applicable)
Prognosis
No direct health impact. Lifetime breast cancer risk 45-65% (BRCA1) or 45-85% (BRCA2). Ovarian cancer risk 39-46% (BRCA1) or 10-27% (BRCA2). Risk-reducing surgery dramatically reduces cancer risk.
Prevention
- Genetic counseling
- Carrier screening
- Prenatal diagnosis
- Preimplantation genetic diagnosis
- Family planning
Research Status
Risk-reducing mastectomy and salpingo-oophorectomy significantly reduce cancer risk. PARP inhibitors (olaparib, rucaparib) for treatment and prevention. Enhanced surveillance (MRI + mammography). Chemoprevention options.
Affected Countries
Sources
- https://www.ncbi.nlm.nih.gov/books/NBK1116
- https://medlineplus.gov/genetics
- https://rarediseases.org
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.